CD
Chanchlesh Dehariya
About Chanchlesh Dehariya
Data last updated:
Chanchlesh Dehariya is a Director at Dermasil Bioceuticals Private Limited (since 2019). The company operates in Chemicals. Dermasil Bioceuticals Private Limited reported revenue of ₹75.4 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Dermasil Bioceuticals Private Limited U24299DL2019PTC352316 | Director | 08 Jul 2019 | 2019 | ₹75.4 Lakh (FY 2025) | Active |
Board colleagues of Chanchlesh Dehariya
| Name | DIN | Company | Designation |
|---|---|---|---|
| Lakhan Kumariya | 08489163 | Dermasil Bioceuticals Private Limited | Director |
| Mohammad Bilal Khan | 09621512 | Dermasil Bioceuticals Private Limited | Director |
| Niharika Mishra | 09258231 | Dermasil Bioceuticals Private Limited | Additional Director |
| Pramod Kumar Das | 08489162 | Dermasil Bioceuticals Private Limited | Director |
| Satya Sundar Panda | 08489153 | Dermasil Bioceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Chanchlesh Dehariya
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chanchlesh Dehariya
Chanchlesh Dehariya currently holds 1 directorship: Dermasil Bioceuticals Private Limited (Director, since 08 Jul 2019, revenue ₹75.4 Lakh (FY 2025)).
Chanchlesh Dehariya was first appointed on 08 Jul 2019 as Director at Dermasil Bioceuticals Private Limited.
The current boards of Chanchlesh Dehariya's companies include Lakhan Kumariya (Dermasil Bioceuticals Private Limited), Mohammad Bilal Khan (Dermasil Bioceuticals Private Limited), Niharika Mishra (Dermasil Bioceuticals Private Limited), Pramod Kumar Das (Dermasil Bioceuticals Private Limited), Satya Sundar Panda (Dermasil Bioceuticals Private Limited).